HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

NCT07466238 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer (BTC)

Interventions

PROCEDURE: HAIC(GOLF)
DRUG: Bevacizumab
DRUG: PD-1/PD-L1 inhibitor
PROCEDURE: HAIC (FOLFOX)
DRUG: Gemcitabin
PROCEDURE: De-escalation strategy
PROCEDURE: Second-line treatment

Sponsor

Peking University